Correspondence with MHRA

The request was successful.

Dear Commission on Human Medicines,

Please provide correspondence between Professor Munir Pirmohamed and the MHRA from 1st March 2022 referencing COVID-19 vaccines or Yellow Card data.

Yours faithfully,

D Jackson

MHRA Customer Services, Commission on Human Medicines

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: D Jackson
<[FOI #852054 email]> Sent: Wednesday, April 6,
2022 6:22:36 PM To: MHRA Customer Services Subject: Freedom of Information
request - Correspondence with MHRA Dear Commission on Human Medicines,
Please provide correspondence between Professor Munir Pirmohamed and the
MHRA from 1st March 2022 referencing COVID-19 vaccines or Yellow Card
data. Yours faithfully, D Jackson
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #852054 email] Is [Commission on Human Medicines request email] the wrong
address for Freedom of Information requests to Commission on Human
Medicines? If so, please contact us using this form:
https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

Dear MHRA Customer Services,

Further to my request:

"Please provide correspondence between Professor Munir Pirmohamed and the MHRA from 1st March 2022 referencing COVID-19 vaccines or Yellow Card data."

I realise "from 1st March" may be ambiguous. Just to clarify, this should be correspondence on or after 1st March.

Yours sincerely,

D Jackson

MHRA Customer Services, Commission on Human Medicines

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: D Jackson
<[FOI #852054 email]> Sent: Thursday, April 7, 2022
12:03:06 PM To: MHRA Customer Services Subject: RE: Freedom of Information
request - Correspondence with MHRA Dear MHRA Customer Services, Further to
my request: "Please provide correspondence between Professor Munir
Pirmohamed and the MHRA from 1st March 2022 referencing COVID-19 vaccines
or Yellow Card data." I realise "from 1st March" may be ambiguous. Just to
clarify, this should be correspondence on or after 1st March. Yours
sincerely, D Jackson -----Original Message----- Thank you for your email.
This auto-response is to inform you that your email has been received and
will be reviewed by our Customer Service Team. We will respond to you as
soon as possible. Please note that we may not respond if your query: •
contains offensive language • has already been answered in a previous
reply to you • is illegible • is selling or promoting a product • is for
information only Medicines and Healthcare products Regulatory Agency 10
South Colonnade, Canary Wharf, London E14 4PU gov.uk/mhra Stay connected
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. The UK has left the EU, and the transition period ends on
31 December 2020. Ourguidance and information can be accessed here.
________________________________________ From: D Jackson <[FOI #852054
email]> Sent: Wednesday, April 6, 2022 6:22:36 PM To: MHRA Customer
Services Subject: Freedom of Information request - Correspondence with
MHRA Dear Commission on Human Medicines, Please provide correspondence
between Professor Munir Pirmohamed and the MHRA from 1st March 2022
referencing COVID-19 vaccines or Yellow Card data. Yours faithfully, D
Jackson
------------------------------------------------------------------- Please
use this email address for all replies to this request: [FOI #852054
email] Is [Commission on Human Medicines request email] the wrong address
for Freedom of Information requests to Commission on Human Medicines? If
so, please contact us using this form:
https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #852054 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Commission on Human Medicines

Our Ref: FOI 22/605

Dear D Jackson,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 7 April 2022.

We confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000

show quoted sections

Dear FOI Team,

Please provide an update on the progress of this request.

Yours sincerely,

D Jackson

MHRA Customer Services, Commission on Human Medicines

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: D Jackson
<[FOI #852054 email]> Sent: Wednesday, May 25, 2022
8:19:50 AM To: MHRA Customer Services Subject: Re: FOI 22/605 Freedom of
Information request - Correspondence with MHRA Dear FOI Team, Please
provide an update on the progress of this request. Yours sincerely, D
Jackson -----Original Message----- Our Ref: FOI 22/605 Dear D Jackson, RE:
REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your
enquiry which we received on 7 April 2022. We confirm that your request is
now being handled under the Freedom of Information Act and you should
receive a reply within 20 working days from our date of receipt. If you
need to contact us again about this request, please quote the reference
number above. Please be aware that we publish FOIs replies and these are
redacted and are located on our website at the following link below.
https://eur01.safelinks.protection.outlo...
Kind Regards, MHRA Customer Experience Centre Communications and
engagement team Medicines and Healthcare products Regulatory Agency 10
South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #852054 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

D Jackson left an annotation ()

IC-174035-P1B1

MHRA Customer Services, Commission on Human Medicines

10 Attachments

Our Ref: FOI 22/605

 

       

Dear Mr/Ms Jackson,

 

Please see the attached response to your enquiry.

 

Kind Regards,

 

 

 

MHRA Customer Experience Centre

Communications and engagement team

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000

 

 

 

 

 

DISCLAIMER This email and any files transmitted with it are confidential.
If you are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this email is
prohibited and may be unlawful. If you are not the intended recipient,
please notify the sender immediately by using the reply function and then
permanently delete what you have received. Incoming and outgoing email
messages are routinely monitored for compliance with the Department of
Health's policy on the use of electronic communications. For more
information on the Department of Health's email policy, click
[1]DHTermsAndConditions

References

Visible links
1. https://www.gov.uk/help/terms-conditions